Mahkam Zanganeh

SMMT

Mahkam Zanganeh serves as director, 10 percent owner, officer: Co-Chief Executive Officer at Summit Therapeutics Inc. (SMMT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

6 trades

$82.56M

Total Sells

1 trades

$6.30M

Net Position

Net Buyer

$76.26M

Companies Traded

SMMT

Active Period

Mar 2023 – Jun 2026

7 total trades

Most Recent

Buy SMMT

Jun 12, 2026 · $49.99M

Mahkam Zanganeh's Insider Trading at Summit Therapeutics Inc. (SMMT)

Buys

6 · $82.56M

Sells

1 · $6.30M

Total Shares Bought

27,890,759

Total Shares Sold

3,985,055

SMMT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 12, 2026	Buy	3,810,000	$13.12	$49.99M	573,883,904
Jun 4, 2026	Buy	100,000	$14.60	$1.46M	25,824,474
Sep 10, 2025	Buy	338,394	$17.69	$5.98M	0
Apr 8, 2025	Sell	3,985,055	$1.58	$6.30M	0
Mar 27, 2024	Buy	110,321	$3.73	$411.1K	24,923,800
Dec 13, 2023	Buy	5,000	$2.07	$10.3K	494,814
Mar 8, 2023	Buy	23,527,044	$1.05	$24.70M	23,395,268

Related Insiders

DUGGAN ROBERT W

director, 10 percent owner, officer: Co-Chief Executive Officer

SMMTBuy · Jun 12, 2026

Manmeet Singh Soni

director, officer: COO and CFO

SMMTBuy · Jun 4, 2026

Yu Xia

Director

SMMTBuy · Oct 21, 2025

Explore More Insider Trading Data

SMMT Insider Trading Activity

View all insider trades at Summit Therapeutics Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity